In silico human cardiomyocyte action potential modeling : exploring ion channel input combinations
dc.contributor.author | Boulay, Emmanuel | |
dc.contributor.author | Troncy, Éric | |
dc.contributor.author | Jacquemet, Vincent | |
dc.contributor.author | Huang, Hai | |
dc.contributor.author | Pugsley, Michael | |
dc.contributor.author | Downey, Anne-Marie | |
dc.contributor.author | Venegas Baca, Rafael | |
dc.contributor.author | Authier, Simon | |
dc.date.accessioned | 2024-08-26T14:46:06Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2024-08-26T14:46:06Z | |
dc.date.issued | 2024-03-13 | |
dc.identifier.uri | http://hdl.handle.net/1866/33748 | |
dc.publisher | SAGE | fr |
dc.subject | In silico | fr |
dc.subject | O’Hara Rudy model | fr |
dc.subject | Action potential duration | fr |
dc.subject | Torsade de pointes | fr |
dc.subject | hERG | fr |
dc.subject | CiPA | fr |
dc.title | In silico human cardiomyocyte action potential modeling : exploring ion channel input combinations | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de pharmacologie et physiologie | fr |
dc.identifier.doi | 10.1177/10915818241237988 | |
dcterms.abstract | In silico modeling offers an opportunity to supplement and accelerate cardiac safety testing. With in silico modeling, computational simulation methods are used to predict electrophysiological interactions and pharmacological effects of novel drugs on critical physiological processes. The O’Hara-Rudy’s model was developed to predict the response to different ion channel inhibition levels on cardiac action potential duration (APD) which is known to directly correlate with the QT interval. APD data at 30% 60% and 90% inhibition were derived from the model to delineate possible ventricular arrhythmia scenarios and the marginal contribution of each ion channel to the model. Action potential values were calculated for epicardial, myocardial, and endocardial cells, with action potential curve modeling. This study assessed cardiac ion channel inhibition data combinations to consider when undertaking in silico modeling of proarrhythmic effects as stipulated in the Comprehensive in Vitro Proarrhythmia Assay (CiPA). As expected, our data highlight the importance of the delayed rectifier potassium channel (IKr) as the most impactful channel for APD prolongation. The impact of the transient outward potassium channel (Ito) inhibition on APD was minimal while the inward rectifier (IK1) and slow component of the delayed rectifier potassium channel (IKs) also had limited APD effects. In contrast, the contribution of fast sodium channel (INa) and/or L-type calcium channel (ICa) inhibition resulted in substantial APD alterations supporting the pharmacological relevance of in silico modeling using input from a limited number of cardiac ion channels including IKr, INa, and ICa, at least at an early stage of drug development. | fr |
dcterms.isPartOf | urn:ISSN:1091-5818 | fr |
dcterms.isPartOf | urn:ISSN:1092-874X | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | DOI: 10.1177/10915818241237988 | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | International journal of toxicology | fr |
oaire.citationVolume | 43 | fr |
oaire.citationIssue | 4 | fr |
oaire.citationStartPage | 357 | fr |
oaire.citationEndPage | 367 | fr |
Fichier·s constituant ce document
Ce document figure dans la ou les collections suivantes
Ce document diffusé sur Papyrus est la propriété exclusive des titulaires des droits d'auteur et est protégé par la Loi sur le droit d'auteur (L.R.C. (1985), ch. C-42). Il peut être utilisé dans le cadre d'une utilisation équitable et non commerciale, à des fins d'étude privée ou de recherche, de critique ou de compte-rendu comme le prévoit la Loi. Pour toute autre utilisation, une autorisation écrite des titulaires des droits d'auteur sera nécessaire.